• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [146 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2008 Institute for Clinical Effectiveness and Health Policy (IECS) T-cell vaccines for the treatment of multiple sclerosis
2008 HAYES, Inc. Pentacel (Sanofi Pasteur Ltd.) for active immunization of infants and children
2008 Health Information and Quality Authority (HIQA) The role of human papillomavirus vaccines in reducing the risk of cervical cancer in Ireland
2008 NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2008 Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against cervical cancer
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The measels-mumps-rubella vaccination from a health political and economical point of view]
2007 Andalusian Health Technology Assessment Area (AETSA) [Vaccine for primary prophylaxis against human papillomavirus infection]
2007 Belgian Health Care Knowledge Centre (KCE) Cost-effectiveness analysis of rotavirus vaccination of Belgian infants
2007 Canadian Agency for Drugs and Technologies in Health (CADTH) Nicotine vaccines for smoking cessation
2007 Belgian Health Care Knowledge Centre (KCE) HPV vaccination for the prevention of cervical cancer in Belgium
2007 HAYES, Inc. Hepatitis A vaccine
2007 Canadian Agency for Drugs and Technologies in Health (CADTH) Grazax: an oral vaccine for the treatment of grass pollen allergy (Hay fever)
2007 Canadian Agency for Drugs and Technologies in Health (CADTH) Human papillomavirus (HPV) vaccines: A Canadian update
2007 NIHR Horizon Scanning Centre (NIHR HSC) INGN 201 (contusugene ladenovec; Advexin) for recurrent and/or unresectable squamous cell carcinoma of the head and neck
2007 NIHR Horizon Scanning Centre (NIHR HSC) INGN 201 (contusugene ladenovec; Advexin) for Li-Fraumeni syndrome associated cancers
2006 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for HIV
2006 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Metastatic melanoma vaccines
2006 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for avian influenza
2006 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccine for herpes simplex
2006 NIHR Horizon Scanning Centre (NIHR HSC) Oncophage for renal cell carcinoma - horizon scanning review
2006 NIHR Horizon Scanning Centre (NIHR HSC) Grazax allergy vaccine for moderate to severe seasonal allergic rhinitis (grass pollen hay fever): horizon scanning review
2006 Institute for Clinical Effectiveness and Health Policy (IECS) Efficacy of the human papillomavirus (HPV) vaccine
2006 HAYES, Inc. Active specific immunotherapy with therapeutic melanoma vaccines
2006 HAYES, Inc. Human papillomavirus vaccines for prevention of cervical cancer
2006 Belgian Health Care Knowledge Centre (KCE) Effects and costs of pneumococcal conjugate vaccination of Belgian children
2005 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Effectiveness and cost-effectiveness of general immunisation of infants and young children with the heptavalent conjugated pneumococcal vaccine
2005 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for prevention of human papillomavirus infection
2005 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for metastatic hormone-refractory prostate cancer
2004 NIHR Horizon Scanning Centre (NIHR HSC) aTL (autologous tumour vaccine) for stage I-III renal cell carcinoma - horizon scanning review
2004 West Midlands Health Technology Assessment Collaboration (WMHTAC) Influenza vaccination of health care workers (HCW) to reduce influenza-related outcomes in high risk patients: a systematic review of clinical and cost-effectiveness
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Palivizumab (Synagis)
2003 The Swedish Council on Health Technology Assessment (SBU) Tumor vaccination- early assessment briefs (Alert)
2003 NIHR Health Technology Assessment programme Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age
2003 HAYES, Inc. Pneumococcal conjugate vaccine for young children
2003 Health Council of the Netherlands Gezondheidsraad (GR) Pneumococcal vaccine in elderly adults and risk groups
2003 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Vaccination for the treatment of melanoma]
2003 Canadian Task Force on Preventive Health Care (CTFPHC) Prevention of influenza in the general population: systematic review and recommendations
2003 NIHR Health Technology Assessment programme Systematic review and economic decision modelling for the prevention and treatment of influenza A and B
2000 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Influenza vaccination of the elderly (funded by DIHTA)]
2000 Health Council of the Netherlands Gezondheidsraad (GR) Vaccination policies in case of an influenza pandemic
2000 Alberta Heritage Foundation for Medical Research (AHFMR) Hepagene vaccine
2000 HAYES, Inc. Hepatitis A vaccine
2000 HAYES, Inc. Meningococcal polysaccharide vaccine and its use in college students
1997 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Efficacy of serogroup C meningococcal polysaccharide vaccine. IPE-97/10 (Public report)
1996 University of York Influenza vaccination and older people
1995 U. S. Congress. Office of Technology Assessment (OTA) Issues in the development of an AIDS vaccine